By May 20, the Japanese government is expected to approve the use of COVID-19 vaccines developed by the AstraZeneca PLC and Moderna Inc, as reported today by the financial newspaper “The Nikkei”.
Ministry of Health officials are planning a meeting around this date to discuss approving the use of vaccines, according to the same post.
The only new coronavirus vaccine approved in Japan so far, this is what Pfizer Inc. and BioNTech SE have developed, as AMPE notes.
Approvals for other vaccines are widely expected to be announced later this month, although no specific dates have been announced.
Prime Minister Yoshihide Suga has pledged to provide several doses of vaccines to the population of Japan’s 126 million people by June and before the 23rd of July, opening day of the Tokyo Olympics.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
